Crestline Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding XAGE
LA
PSAMP
SC
AC
PC
AA
TAM
Crestline Management's XAGE Position: Q1 2022 in Review
Crestline Management sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q1 2022, closing a stake of 2,500 shares — an estimated $725K sold.
Crestline Management first reported a position in XAGE in Q3 2021 and held it in 2 quarters. The position peaked at $726K in Q3 2021. 27 funds tracked by Wall St. Rank hold XAGE as of Q1 2022.
- Crestline Management reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- Crestline Management sold 2,500 Longevity Health Holdings, Inc. Common Stock shares in Q1 2022, an estimated $725K.
- Crestline Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
- Crestline Management's Longevity Health Holdings, Inc. Common Stock position peaked at $726K in Q3 2021.
- 27 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q1 2022.
Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.